We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Rapid initiation protocol for naltrexone for OUD.
- Authors
Knopf, Alison
- Abstract
Your idea of "rapid" may be different from that of the National Institute on Drug Abuse (NIDA), which funded a study showing that it is possible to start patients on injectable, extended‐release naltrexone (trade name Vivitrol) within five to seven days after they stop opioid use — and called that "rapid initiation." But it's all relative. The standard treatment method was within 10–15 days, according to NIDA. The new finding shortens that painful period.
- Subjects
MEDICAL protocols; SUBSTANCE abuse; COST control; CONTROLLED release preparations; DRUG withdrawal symptoms; CLONIDINE; NATIONAL Institute on Drug Abuse; CLONAZEPAM; NALTREXONE; DRUGS of abuse; FENTANYL
- Publication
Brown University Child & Adolescent Psychopharmacology Update, 2024, Vol 26, Issue 7, p5
- ISSN
1527-8395
- Publication type
Article
- DOI
10.1002/cpu30877